封面
市場調查報告書
商品編碼
2052282

彈性體輸液幫浦市場:依產品類型、治療領域、最終用戶和地區分類

Elastomeric Infusion Pumps Market, By Product Type, By Treatment, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,彈性體輸液幫浦市場規模將達到 23.59 億美元,到 2033 年將達到 26.188 億美元。預計從 2026 年到 2033 年,該市場將以 9.6% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 23.59億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 9.60% 2033年市場規模預測: 26.188億美元

彈性體輸液泵,又稱球囊泵,是一種非電子輸液泵,用於輸注鎮痛藥、化療藥物、局部麻醉劑、抗生素及其他類型的藥物。彈性體輸液幫浦為一次性醫療設備,用於藥物輸注。輸注過程由泵浦內彈性體層產生的恆定壓力完成,該壓力由位於彈性體儲液器內的流量限制器控制。

市場動態

慢性疾病(例如癌症)盛行率的上升預計將推動市場成長。例如,根據世界衛生組織(世衛組織)2022年2月3日發布的一份情況說明書,2021年約有1000萬人死於癌症,這意味著約六分之一的死亡是由癌症引起的,使其成為全球首要死因。乳癌、肺癌、大腸癌、直腸癌和攝護腺癌是最常見的癌症類型。此外,根據世衛組織統計,每年約有40萬名兒童被診斷出罹患癌症。因此,鑑於癌症的高發生率,預計全球彈性體輸液幫浦市場在預測期內將持續成長。

此外,彈性體輸液幫浦比電子輸液幫浦價格更低、副作用更少,因此在門診化療中心的應用日益廣泛。另外,由於彈性體輸液幫浦無需電力即可運行,因此消除了藥物無動力輸注給患者的風險。彈性體輸液幫浦相對於電子輸液幫浦的這些優勢預計將推動市場成長。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數對全球彈性體輸液幫浦市場的主要參與者進行了分析:公司概況、產品系列、主要亮點、財務績效和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球彈性體輸液幫浦市場報告旨在為產業內的各種相關人員提供參考,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過對全球彈性體輸液幫浦市場進行分析時所使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
  • 影響分析
  • 主要亮點
  • 宣傳活動
  • PEST分析
  • 流行病學

第4章 全球彈性體輸液幫浦市場:依產品類型分類,2021-2033年

  • 可變流量彈性體泵
  • 恆速彈性體泵

第5章 全球彈性體輸液幫浦市場:依治療領域分類,2021-2033年

  • 疼痛管理
  • 抗生素/抗病毒藥物
  • 化療
  • 其他

第6章 全球彈性體輸液幫浦市場:依最終用戶分類,2021-2033年

  • 門診手術中心
  • 診所
  • 居家醫療
  • 醫院
  • 其他

第7章 全球彈性體輸液幫浦市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • Braun Melsungen AG
  • Fresenius Kabi
  • Leventon, SAU
  • Ambu A/S
  • Baxter International Inc.
  • Halyard Health
  • Nipro Corporation

第9章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第10章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI3129

Elastomeric Infusion Pumps Market is estimated to be valued at USD 2,359.0 Mn in 2026 and is expected to reach USD 2,618.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2,359 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.60% 2033 Value Projection: USD 2,618.8 Mn

Elastomeric infusion pumps are non-electronic medication pumps also called as balloon pumps which are used for infusion of analgesics, chemotherapy drugs, local anesthetics, antibiotics and other type of medications. Elastomeric infusion pumps are single use medical devices used for drug infusion. The process of infusion is carried out with the help of consistent pressure created in the elastomeric layer present in the pump which is controlled with the help of flow restrictors located in the elastomeric reservoir.

Market Dynamics

Increase in the prevalence of chronic diseases like cancer is expected to propel growth of market. For instance, according to factsheet published by World Health Organization (WHO) on 3 February, 2022, nearly 10 million deaths, or nearly one in six deaths were caused by cancer in 2021, making it the leading cause of death globally. Breast, lung, colon, rectum, and prostate cancers are the most prevalent types of cancer. In addition, according to WHO, each year, approximately 400,000 children develop cancer. Thus due to prevalence of cancer the global elastomeric infusion pumps market is expected grow over the forecast period.

Moreover, elastomeric infusion pumps are cheaper and have fewer adverse effects compared to electronic pumps, which increases their adoption in ambulatory chemotherapy infusion centers. Moreover, as elastomeric infusion pumps do not require electricity to operate, the risk for free flow of medication to patients is eliminated. Such advantages of elastomeric infusion pumps over their electric counterparts is also expected to boost growth of market.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global elastomeric infusion pumps market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global elastomeric infusion pumps market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global elastomeric infusion pumps market

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Variable Rate Elastomeric Pumps
  • Continuous Rate Elastomeric Pumps
  • Treatment Insights (Revenue, USD Mn, 2021 - 2033)
  • Pain management
  • Antibiotic/Antiviral
  • Chemotherapy
  • Others
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Ambulatory Surgical Centers
  • Clinics
  • Home Care Settings
  • Hospitals
  • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • B. Braun Melsungen AG
  • Fresenius Kabi
  • Leventon
  • S.A.U
  • Ambu A/S
  • Baxter International Inc.
  • Halyard Health
  • Nipro Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Treatment
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Awareness Initiatives
  • PEST Analysis
  • Epidemiology

4. Global Elastomeric Infusion Pumps Market, By Product Type, 2021 - 2033, (USD Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Variable Rate Elastomeric Pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Continuous Rate Elastomeric Pumps
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

5. Global Elastomeric Infusion Pumps Market, By Treatment, 2021 - 2033, (USD Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Antibiotic/Antiviral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)

6. Global Elastomeric Infusion Pumps Market, By End User, 2021 - 2033, (USD Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)

7. Global Elastomeric Infusion Pumps Market, By Region, 2021 - 2033, (USD Million)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Million)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Million)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fresenius Kabi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Leventon, S.A.U
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ambu A/S
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Halyard Health
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nipro Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact